| Price | 7.45p on 05-05-2026 at 11:30:14 |
|---|---|
| Change | -0.45p -5.7% |
| Buy | 7.50p |
| Sell | 7.40p |
| Last Trade: | Sell 76,281.00 at 7.45p |
| Day's Volume: | 2,513,185 |
| Last Close: | 7.90p |
| Open: | 7.60p |
| ISIN: | GB00BYV81293 |
| Day's Range | 7.45p - 7.60p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £79.60m |
| VWAP: | 7.530827p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 76,281 | 7.45p | Ordinary |
12:27:17 - 05-May-26 |
| Sell* | 10,000 | 7.426p | Ordinary |
12:11:38 - 05-May-26 |
| Sell* | 89,294 | 7.42p | Ordinary |
11:48:38 - 05-May-26 |
| Sell* | 100,000 | 7.416p | Ordinary |
11:39:53 - 05-May-26 |
| Buy* | 300,000 | 7.47p | Ordinary |
10:43:53 - 05-May-26 |
| Sell* | 19,850 | 7.426p | Ordinary |
10:42:55 - 05-May-26 |
| Sell* | 35,000 | 7.426p | Ordinary |
10:39:38 - 05-May-26 |
| Buy* | 20,000 | 7.468p | Ordinary |
10:18:20 - 05-May-26 |
| Sell* | 6,000 | 7.40p | Ordinary |
10:17:22 - 05-May-26 |
| Sell* | 40,201 | 7.40p | Ordinary |
09:38:47 - 05-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
